Project Grant R01HD124419
- The National Institute of Child Health and Human Development awarded Thomas Jefferson University $438,910 on August 17, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and pilot a group-based well-child care model that integrates maternal healthcare for mothers with hypertensive disorders of pregnancy. The recipient will execute two primary aims. In Aim 1, the institution will conduct a user-centered design process including focus groups...
- The National Institute of Child Health and Human Development awarded Emory University $426,948 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and validate artificial intelligence models that integrate electronic health record data to identify clinically meaningful subtypes of hypertensive disorders of pregnancy and predict disease onset before clinical diagnosis. The project will model longitudinal physiological changes and...
- The National Institutes of Health Office of the Director awarded the Board of Regents of the University of Nebraska, acting through its University of Nebraska Medical Center division, $565,185 on August 17, 2026, for a randomized mechanistic clinical trial testing a collaborative care intervention for postpartum hypertension in Black women under the Cardiovascular Diseases Research program (CFDA 93.837). The study, titled PRIME CARE (Postpartum Remote Monitoring and Integration of Mobile...
- The National Institute of Child Health and Human Development awarded $568,925 to the Board of Regents of the University of Nebraska on September 1, 2026, to conduct pharmacokinetic, pharmacodynamic, safety, and efficacy studies of targeted nanoparticle drug delivery to the placenta under CFDA 93.865 (Child Health and Human Development Extramural Research). The research addresses placental dysfunction, the underlying cause of preeclampsia, intrauterine growth restriction, and stillbirth, which...
- The National Institute of Child Health and Human Development awarded Cincinnati Children's Hospital Medical Center $164,808 on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to support a five-year research and career development project led by Dr. Sump focused on digital health interventions for infants with poor weight gain. The project adapts an existing mHealth intervention originally developed for hospitalized infants into a comprehensive...
- Federal Project Grant Award Summary The University of Kansas Medical Center Research Institute, Inc. received a $426,250 Project Grant award dated August 6, 2025, from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award supports research through July 31, 2027, investigating the role of Protein Arginine Methyltransferase 1 (PRMT1) in regulating trophoblast development and...
- The National Institute of Child Health and Human Development awarded The General Hospital Corporation (Massachusetts General Hospital) $443,954 on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to conduct a four-year mixed-methods assessment of obstetric readiness in low-resource emergency departments. The research addresses the clinical gap created by closures of labor and delivery units that leave 2.3 million women of childbearing age in...
- The National Institute of Child Health and Human Development awarded The Children's Hospital of Philadelphia $795,088 on June 15, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to conduct a cluster randomized controlled trial evaluating doula support and healthcare navigation for mothers of preterm infants in neonatal intensive care units. The study, titled Postpartum Care in the NICU (PELICAN), addresses maternal postpartum mortality risk among...
- The National Institute of Child Health and Human Development awarded the University of North Carolina at Chapel Hill $797,615 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to optimize the SAFE Families intervention, a family-centered program designed to improve health and developmental outcomes for children who are HIV-exposed and uninfected. The award funds a randomized factorial trial enrolling 384 mothers living with HIV during...
- The National Institute of Child Health and Human Development awarded $436,100 to the University of North Carolina at Charlotte on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and validate non-invasive high-resolution fetal HLA and KIR genotyping protocols using cell-free DNA from maternal blood. The project addresses preeclampsia risk stratification in early pregnancy by developing a high-resolution HLA genotyping protocol...
The National Institute of Child Health and Human Development awarded the University of Kansas Medical Center Research Institute, Inc. $535,183 on August 26, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to evaluate the Healthy Outcomes for Pregnancy and Expected Parents (HOPE) intervention, a multilevel, patient-centered approach to prevent hypertensive disorders of pregnancy in high-risk populations. The HOPE intervention addresses barriers to adherence to evidence-based prevention strategies—including low-dose aspirin and blood pressure monitoring—in low-income communities by integrating individual-level support through Bluetooth blood pressure monitors and wearable devices; interpersonal support via doula check-ins to reinforce aspirin adherence and monitoring; group-level support through seven virtual doula-led sessions; and a community-health systems linkage model to strengthen patient-provider communication. The study design is a two-arm cluster randomized controlled trial comparing HOPE (treatment) against standard prenatal care with access to doula services (control) among 700 high-risk pregnant females, guided by the Health Belief Model and Social Cognitive Theory. Performance is located in Kansas City, Kansas, with a period of performance from August 26, 2026, through July 31, 2031. The award is structured as a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $535.2k | 8/27/26 |